|
Represented a former collateral manager for various collateralized debt obligations from a major financial institution in connection with an inquiry by the SEC and Antitrust Division of the Department of Justice for which no charges were ever brought.
|
|
Conducted an internal investigation of a rating company concerning its methodology for rating ABS CDOs and contested ratings of certain transactions.
|
|
Represents a prominent former portfolio manager for a significant hedge fund in governmental investigations and a civil class action regarding alleged commodities manipulation.
|
|
Represents creditors’ committee in conducting significant investigation into potential estate claims against affiliated party.
|
|
Represented numerous former and current employees of an international financial institution in a joint state and federal criminal investigation involving compliance with U.S. sanctions laws and regulations. No charges were brought against any of the individuals.
|
|
Represents a senior employee at a global financial institution in a coordinated investigation conducted by the DOJ, FBI, SEC, CFTC and the United Kingdom's FSA.
|
|
Defended a subsidiary of Johnson & Johnson against a Robinson- Patman antitrust action brought by one of its distributors before a jury in the Southern District of New York and secured an award of millions on its counterclaims.
|
|
Represented a biotech biodense company in a trial in Delaware Chancery Court against another biotech company regarding the development and licensing of an anti-viral drug to combat smallpox.
|
|
Represented a subsidiary of Johnson & Johnson in an expedited arbitration against a major pharmaceutical company regarding distribution rights to purchase rapid-exchange catheters for use with coronary stents.
|
|
Defended a subsidiary of Johnson & Johnson in an action brought by a major pharmaceutical company regarding the scope of its rights to distribute a fully human anti-TNF monoclonal antibody.
|
|
Represented a medical device company engaged in the diagnosis and treatment of vascular disease in a dispute with a physician researcher regarding his rights under a Joint Venture Agreement and Shareholder's Agreement.
|
|
Represented McNeil-PPC, Inc., a subsidiary of Johnson & Johnson, in obtaining an injunction in federal court against Pfizer, Inc.’s widespread advertising that Listerine is “as effective as floss.” See McNeil-PPC, Inc. v. Pfizer, Inc., 351 F. Supp. 2d 226 (S.D.N.Y. 2005).
|
|
Defended a global consumer products company and other companies in a false advertising and consumer fraud nationwide class action brought on behalf of women and men who purchased skin care products advertised as “anti-aging.”
|
|
Represented a hedge fund in resolving contract and CEPA whistleblower claims brought by a former executive.
|
|
Defended a national law firm against claims by a former employee of sexual harassment in a jury trial in New York State Supreme Court, which was ultimately favorably resolved mid-trial to the satisfaction of the firm.
|
|
Represented a global professional services firm in defending against a federal ERISA action brought by the former president and chief operating officer of one of its subsidiaries regarding his severance benefits.
|
|
Represented a renowned scientific research organization in a federal employment discrimination and copyright case brought by a former research scientist.
|
|
Represented a major medical center in defending against a federal First Amendment and gender discrimination claim brought by a former employee.
|
|
Represented a telecommunications company in an appeal to the First Department Appellate Division regarding the applicability of certain municipal tax provisions.
|